HLA-DP表达在非血缘供者移植后移植物抗宿主病中的作用
该研究评估了HLA-DPB1表达水平在HLA-A、-B、-C、-DRB1、-DQB1匹配或不匹配非血缘供者造血细胞移植后急性GVHD中的意义。在HLA-A、-B、-C、-DRB1、-DQB1匹配的移植受者中,供者针对患者高表达HLA-DPB1错配增加了中度(OR 1.36)和重度(OR 1.32)急性GVHD风险;在HLA不匹配受者中,HLA-DPB1错配数量增加与急性GVHD风险增加相关。
要点
- HLA-A、-B、-C、-DRB1、-DQB1匹配移植中,供者针对患者高表达HLA-DPB1错配增加中度和重度急性GVHD风险。
- HLA不匹配移植中,HLA-DPB1错配数量增加与急性GVHD风险增加相关。
- 患者HLA-DPB1错配表达水平可指导HLA匹配非血缘移植的GVHD风险评估。
核心结论
- 患者HLA-DPB1错配的表达水平可指导HLA-A、-B、-C、-DRB1、-DQB1匹配非血缘HCT后的GVHD风险。
- HLA-DPB1错配总数可指导HLA不匹配非血缘HCT后的GVHD风险。
- 作者认为前瞻性考虑HLA-DPB1可能有助于降低移植后GVHD风险。
研究设计与样本
- 研究评估了2017年1月1日至2019年1月10日期间评估的19,136例接受HLA-A、-B、-C、-DRB1、-DQB1匹配或不匹配非血缘供者HCT的患者,移植于1988年至2016年在澳大利亚、欧盟、日本、北美和英国进行。
- 在具有一个HLA-DPB1错配的移植受者中,患者错配的HLA-DPB1同种异型被定义为低表达或高表达。
- 采用多变量回归模型评估高表达相对于低表达HLA-DPB1错配相关的GVHD风险。
- 在HLA不匹配移植受者中评估了增加HLA-DPB1错配数量对临床结局的影响。
主要发现
- 在HLA-A、-B、-C、-DRB1、-DQB1匹配移植受者中,供者针对一个高表达患者HLA-DPB1错配相对于低表达患者错配增加了中度急性GVHD(OR 1.36;P=0.001)和重度急性GVHD(OR 1.32;P=0.0016),与供者错配HLA-DPB1的表达水平无关。
- 在具有一个HLA-A、-B、-C、-DRB1或-DQB1错配的移植受者中,急性GVHD的比值比随HLA-DPB1错配数量增加而增加:中度GVHD相对于零错配,一个错配OR 1.23,两个错配OR 1.40;重度GVHD相对于零错配,一个错配OR 1.19,两个错配OR 1.40。
- 在具有一个HLA-A、-B、-C、-DRB1或-DQB1错配的移植受者中,急性GVHD风险与患者错配HLA-DPB1同种异型的表达水平无关。
临床怎么用
- 作者认为前瞻性考虑HLA-DPB1可能有助于降低移植后GVHD风险。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The main aim of this study was to evaluate the significance of HLA-DPB1 expression in acute graft-versus-host disease (GVHD) after hematopoietic cell transplantation (HCT) from HLA-A, -B, -C, -DRB1, -DQB1-matched and -mismatched unrelated donors. PATIENTS AND METHODS: Between January 1, 2017, and January 10, 2019, we assessed 19,136 patients who received HCT from an HLA-A, -B, -C, -DRB1, -DQB1-matched or -mismatched unrelated donor performed in Australia, the European Union, Japan, North America, and the United Kingdom between 1988 and 2016. Among transplant recipients with one HLA-DPB1 mismatch, the patient's mismatched HLA-DPB1 allotype was defined as low or high expression. Multivariable regression models were used to assess risks of GVHD associated with high expression relative to low expression HLA-DPB1 mismatches. The effect of increasing numbers of HLA-DPB1 mismatches on clinical outcome was assessed in HLA-mismatched transplant recipients. RESULTS: In HLA-A, -B, -C, -DRB1,-DQB1-matched transplant recipients, donor mismatching against one high-expression patient HLA-DPB1 increased moderate (odds ratio [OR], 1.36; P = .001) and severe acute GVHD (OR, 1.32; P = .0016) relative to low-expression patient mismatches, regardless of the expression level of the donor's mismatched HLA-DPB1. Among transplant recipients with one HLA-A, -B, -C, -DRB1, or -DQB1 mismatch, the odds of acute GVHD increased with increasing numbers of HLA-DPB1 mismatches (OR, 1.23 for one; OR, 1.40 for two mismatches relative to zero mismatches for moderate GVHD; OR, 1.19 for one; OR, 1.40 for two mismatches relative to zero for severe GVHD), but not with the level of expression of the patient's mismatched HLA-DPB1 allotype. CONCLUSION: The level of expression of patient HLA-DPB1 mismatches informs the risk of GVHD after HLA-A, -B, -C, -DRB1, -DQB1-matched unrelated HCT, and the total number of HLA-DPB1 mismatches informs the risk of GVHD after HLA-mismatched unrelated HCT. Prospective consideration of HLA-DPB1 may help to lower GVHD risks after transplantation.
引用
- Petersdorf EW, Bengtsson M, De Santis D, et al. Role of HLA-DP Expression in Graft-Versus-Host Disease After Unrelated Donor Transplantation. J Clin Oncol. 2020. PMID: 32479188. doi:10.1200/JCO.20.00265
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。